Roshni is working in our Therapeutic Discovery team aimed at identifying and evaluating ARCUS nucleases in disease relevant cell models. Before joining Precision, Roshni worked at RaNA Therapeutics where she led the in vitro discovery efforts for SMA, a neuromuscular disorder. Prior to RaNA, she worked at Alnylam Pharmaceuticals where her work helped secure a key collaboration with GSK for influenza vaccine production in cell based systems. Roshni received her M.S. in biotechnology from Northeastern University in Boston, and her B.Tech in biotechnology from Anna University in India. When Roshni is not at Precision, she is mostly testing her skills at duplicating her mother’s recipes or indulging in the guilty pleasure of watching cheesy Bollywood flicks.